Prescription medicines and public promotion

TGA generally prohibits advertising prescription medicines to the public, with limited exceptions. Whether material is advertising depends on promotional purpose and context; not every public mention has the same status.

Direct or indirect references can include brand names, active ingredients, medicine classes, abbreviations, suggestive substitutes and imagery. Replacing a brand with an ingredient or a phrase such as “weight-loss injections” is not a reliable workaround. Review the full presentation and intended audience against the applicable guidance. TGA prescription medicine guidance, updated 23 June 2026.

What to do in NRS

Keep the draft or finding for review. Record the exact passage and any associated image, link or booking prompt. Ask the responsible reviewer to distinguish the service being described from promotion of a medicine. Do not have an assistant invent a euphemism to evade a flagged term.

If a rewrite is proposed, check its meaning again in the complete advertisement. A generic rule retrieved through Abe does not approve the replacement. Unresolved blocking checks remain a release barrier.

The public reporting workflow is not a place for patient records or prescribing discussions. This guide supports advertising review; it does not assess an individual's treatment or advise which medicine to use. Source review: 8 September 2026.